GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
37.50
+0.47 (1.27%)
At close: Apr 24, 2025, 4:00 PM
37.29
-0.21 (-0.56%)
Pre-market: Apr 25, 2025, 4:35 AM EDT
GSK Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for GSK stock has a target of 47, which predicts an increase of 25.33% from the current stock price of 37.50.
Analyst Consensus: Hold
* Price targets were last updated on May 30, 2024.
Analyst Ratings
The average analyst rating for GSK stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 31, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 8, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $53 → $53 | Strong Buy | Maintains | $53 → $53 | +41.33% | Jul 2, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $47 | Hold | Initiates | $47 | +25.33% | May 30, 2024 |
Financial Forecast
Revenue This Year
33.76B
from 31.38B
Increased by 7.60%
Revenue Next Year
35.53B
from 33.76B
Increased by 5.24%
EPS This Year
1.73
from 0.62
Increased by 178.25%
EPS Next Year
1.92
from 1.73
Increased by 10.93%
Financial currency is GBP. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 35.1B | 38.4B | 41.6B | ||
| Avg | 33.8B | 35.5B | 36.9B | ||
| Low | 31.6B | 32.6B | 33.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.9% | 13.9% | 17.0% | ||
| Avg | 7.6% | 5.2% | 3.9% | ||
| Low | 0.6% | -3.4% | -6.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.89 | 2.18 | 2.50 | ||
| Avg | 1.73 | 1.92 | 2.05 | ||
| Low | 1.46 | 1.61 | 1.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 203.4% | 26.0% | 30.2% | ||
| Avg | 178.2% | 10.9% | 6.6% | ||
| Low | 134.6% | -7.0% | -13.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.